Major Depressive Disorder and Magnetic Resonance Imaging: A Mini-Review of Recent Progress

E-ISSN： 1873-4286|24|22|2524-2529

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.22, 2018-06, pp. : 2524-2529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

‘Hot’ Cognition in Major Depressive Disorder: A Systematic Review

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1787-1803

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Glutamatergic System to Treat Major Depressive Disorder: Rationale and Progress to Date

By Mathews Daniel C.

Drugs, Vol. 72, Iss. 10, 2012-07 ,pp. : 1313-1333

Adis International

Access to resources Recommend Favorite

Vilazodone: In Major Depressive Disorder

By Frampton James E.

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 615-627

Adis International

Access to resources Recommend Favorite

Aripiprazole: In Major Depressive Disorder

By Weber Juliane Lyseng-Williamson Katherine A. Scott Lesley J.

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 807-813

Adis International

Access to resources Recommend Favorite

Sertraline: A Review of its Use in the Management of Major Depressive Disorder in Elderly Patients

By Muijsers R.B.R. Plosker G.L. Noble S.

Drugs & Aging, Vol. 19, Iss. 5, 2002-05 ,pp. : 377-392

Adis International

Access to resources Recommend Favorite